Stay updated on Nivolumab in Malignant Pleural Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Malignant Pleural Mesothelioma Clinical Trial page.

Latest updates to the Nivolumab in Malignant Pleural Mesothelioma Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No substantive changes to study content or page details.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page now shows the revision tag v3.4.3, replacing the previous revision tag v3.4.2.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision updated to v3.4.1 from v3.4.0; no changes to core study content, eligibility criteria, outcomes, or locations observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page now shows a glossary and adds the labels 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Nivolumab in Malignant Pleural Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Malignant Pleural Mesothelioma Clinical Trial page.